ReviewFrontiers in immunology2026
Research progress on the role and dysregulation of NK cells in anti-tuberculosis immunity.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tuberculosis (TB) is one of the most common infectious diseases caused by Mycobacterium tuberculosis (M.tb). The emergence of multidrug-resistant strains, HIV infection, and poor efficacy of the BCG vaccine have made TB epidemics difficult to control. Natural killer (NK) cells are an important component of the body's innate immunity, playing a role not only in the early stages of M.tb infection but also in activating adaptive immune cells to inhibit M.tb proliferation. Recent studies have increasingly revealed significant changes in the number, subsets, and functions of NK cells as TB progresses, with NK cells primarily exhibiting signs of depletion, suggesting a close correlation between NK cell changes and TB progression. Therefore, this article outlines the main changes in NK cells in clinical cohort studies, discusses potential mechanisms of their depletion, and introduces the functions of NK cells, as well as the methods and strategies they use to recognize and kill Mycobacterium tuberculosis. This can contribute to a better understanding of the role and manifestation of NK cells in TB immunity and provide a more comprehensive perspective for NK cell-based TB treatment strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.